Arca
Skip to content

Access BNP II

Test, Natriuretic Peptide. 510(k) K262597, from Beckman Coulter, Inc. (Chaska, MN). Product code NBC, class 2.

As of Nov 17, 2026, K262597 is an FDA 510(k) held by Beckman Coulter, Inc., substantially equivalent on Oct 20, 2026 after 85 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Oct 20, 2026
  • Review time: 85 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Access BNP II test is intended for use with the Beckman Coulter Access Family of Immunoassay Systems for the In Vitro quantitative measurement of B-type natriuretic peptide (BNP) in plasma specimens using EDTA as the anticoagulant.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other NBC Clearances

The newest 510(k)s for the same product code; their median review was 262 days; see every NBC device

Record

Type
Traditional
Received
Jul 27, 2026
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1117

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.